The DOI matches its Crossref record, with a small difference in title or year; 34 of the 35 references it cites were found in a registry or an index.
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Open accessAbstract
BACKGROUND: Recent randomized clinical trials have suggested that estrogen plus progestin does not confer cardiac protection and may increase the risk of coronary heart disease (CHD). In this report, we provide the final results with regard to estrogen plus progestin and CHD from the Women's Health Initiative (WHI). METHODS: The WHI included a randomized primary-prevention trial of estrogen plus progestin in 16,608 postmenopausal women who were 50 to 79 years of age at base line. Participants were randomly assigned to receive conjugated equine estrogens (0.625 mg per day) plus medroxyprogesterone acetate (2.5 mg per day) or placebo. The primary efficacy outcome of the trial was CHD (nonfatal myocardial infarction or death due to CHD). RESULTS: After a mean follow-up of 5.2 years (planned duration, 8.5 years), the data and safety monitoring board recommended terminating the estrogen-plus-progestin trial because the overall risks exceeded the benefits. Combined hormone therapy was associated with a hazard ratio for CHD of 1.24 (nominal 95 percent confidence interval, 1.00 to 1.54; 95 percent confidence interval after adjustment for sequential monitoring, 0.97 to 1.60). The elevation in risk was most apparent at one year (hazard ratio, 1.81 [95 percent confidence interval, 1.09 to 3.01]). Although higher base-line levels of low-density lipoprotein cholesterol were associated with an excess risk of CHD among women who received hormone therapy, higher base-line levels of C-reactive protein, other biomarkers, and other clinical characteristics did not significantly modify the treatment-related risk of CHD. CONCLUSIONS: Estrogen plus progestin does not confer cardiac protection and may increase the risk of CHD among generally healthy postmenopausal women, especially during the first year after the initiation of hormone use. This treatment should not be prescribed for the prevention of cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Although there have been no placebo-controlled trials in children, observational studies have suggested that early treatment can reduce LDL-C burden, improve endothelial function, substantially attenuate the development of atherosclerosis, and improve coronary outcomes [369-371].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [371]
Experimental — accuracy not yet measuredIn the citing paper
“Although there have been no placebo-controlled trials in children, observational studies have suggested that early treatment can reduce LDL-C burden, improve endothelial function, substantially attenuate the development of atherosclerosis, and improve coronary outcomes [369-371].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [371]
In the citing paper
“Although there have been no placebo-controlled trials in children, observational studies have suggested that early treatment can reduce LDL-C burden, improve endothelial function, substantially attenuate the development of atherosclerosis, and improve coronary outcomes [369-371].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [371]
In the citing paper
“Although there have been no placebo-controlled trials in children, observational studies have suggested that early treatment can reduce LDL-C burden, improve endothelial function, substantially attenuate the development of atherosclerosis, and improve coronary outcomes [369-371].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [371]
In the citing paper
“Oestrogen replacement therapy, despite some favourable effects on the lipid profile, has not been demonstrated to reduce CV risk and cannot be recommended for CV prevention in women.166”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [166]
In the citing paper
“Oestrogen replacement therapy, despite some favourable effects on the lipid profile, has not been demonstrated to reduce CV risk and cannot be recommended for CVD prevention in women. 318”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [318]
In the citing paper
“and the higher palatability and acceptance of MeDiets in comparison with low-fat diets 17,18 lend support to our hypothesis.”
From Cohort Profile: Design and methods of the PREDIMED study (2012) · cites this paper as [18]
In the citing paper
“Oestrogen replacement therapy, despite some favourable effects on the lipid profile, has not been demonstrated to reduce CV risk and cannot be recommended for CVD prevention in women.318”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [318]
In the citing paper
“however, hormone replacement therapy does not consistently restore BP, suggesting additional regulatory mechanisms [ 177 ].”
From Sex differences in potassium regulation: evidence, molecular mechanisms and clinical implications (2026) · cites this paper as [177]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
The Protective Effects of Estrogen on the Cardiovascular System
Mendelsohn, M. E., & Karas, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402306 · Cited by 3,119
Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., Mitch, W., Smith, S. C., & Sowers, J. R. (1999) · Circulation · doi:10.1161/01.cir.100.10.1134 · Cited by 2,698
Design of the Women’s Health Initiative Clinical Trial and Observational Study
The Women’s Health Initiative Study Group (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,580
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
Grady, D., Rubin, S. M., Petitti, D. B., Fox, C. S., Black, D. M., Ettinger, B. B., Ernster, V. L., & Cummings, S. R. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1016 · Cited by 2,329
Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy
Grady, D. G., Herrington, D. M., Bittner, V., Blumenthal, R. S., Davidson, M., Hlatky, M. A., Hsia, J. A., Hulley, S. B., Herd, A. J., Khan, S. S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,921
Self-citationEffect of Statin Therapy on C-Reactive Protein Levels
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,644
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Cited by
Sorted by citations
Items 101–200 of 1,001
Coylewright, M. J., Reckelhoff, J. F., & Ouyang, P. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.105742 · Cited by 296
Lønning, P. E., Geisler, J., Krag, L. E., Erikstein, B., Bremnes, Y., Hagen, A. I., Schlichting, E., Lien, E. A., Øfjord, E. S., Paolini, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.097 · Cited by 295
Mortality associated with hormone replacement therapy in younger and older women
Salpeter, S. R., Walsh, J. M. E., Greyber, E., Ormiston, T. M., & Salpeter, E. E. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30281.x · Cited by 294
Maas, A. H. E. M., van der Schouw, Y. T., Regitz‐Zagrosek, V., Swahn, E., Appelman, Y., Pasterkamp, G., Cate, H. T., Nilsson, P. M., Huisman, M. V., Stam, H. C. G., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr048 · Cited by 299
Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke
Napoli, M. D., Schwaninger, M., Cappelli, R., Ceccarelli, E., Gianfilippo, G. D., Donati, C., Emsley, H. C. A., Forconi, S., Hopkins, S. J., Masotti, L., et al. (2005) · Stroke · doi:10.1161/01.str.0000165929.78756.ed · Cited by 290
Contraceptive hormone use and cardiovascular disease
Shufelt, C. L., & Bairey Merz, C. N. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.042 · Cited by 287
Kalantaridou, S. N., Naka, K. K., Papanikolaou, E., Kazakos, N., Kravariti, M., Calis, K. A., Paraskevaidis, E. A., Sideris, D. A., Tsatsoulis, A., Chrousos, G. P., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0015 · Cited by 284
Long term hormone therapy for perimenopausal and postmenopausal women
Marjoribanks, J., Farquhar, C. M., Roberts, H., & Lethaby, A. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004143.pub4 · Cited by 286
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828478ac · Cited by 275
Estrogen, hormonal replacement therapy and cardiovascular disease
Yang, X.-P., & Reckelhoff, J. F. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283431921 · Cited by 276
Barlow, D. H. (2004) · American Psychologist · doi:10.1037/0003-066x.59.9.869 · Cited by 271
Heckbert, S. R., Kooperberg, C. L., Safford, M. M., Psaty, B. M., Hsia, J. A., McTiernan, A., Gaziano, J. M., Frishman, W. H., & Curb, J. D. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh314 · Cited by 268
Self-citationDanaei, G., Tavakkoli, M., & Hernán, M. Á. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr301 · Cited by 275
Prentice, R. L., Langer, R., Stefanick, M. L., Howard, B. V., Pettinger, M. B., Anderson, G. L., Barad, D. H., Curb, J. D., Kotchen, J. M., Kuller, L. H., et al. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi223 · Cited by 263
Disorders of lipid metabolism. Clinical Guidelines 2023
Владиславович, Е. М., Kukharchuk, V. V., Сергиенко, И. В., Alieva, A. S., Antsiferov, M. B., Ansheles, A. A., Arabidze, G. G., Dm, A., Arutyunov, G. P., Ахмеджанов, Н. М., et al. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5471 · Cited by 270
Smith, G. D. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00191.x · Cited by 257
Vickers, M. R., MacLennan, A. H., LAWTON, B. A., Ford, D., Martin, J., Meredith, S. K., Stavola, B. L. D., Rose, S. B., Dowell, A. C., Wilkes, H. C., et al. (2007) · BMJ · doi:10.1136/bmj.39266.425069.ad · Cited by 255
Beyond the Randomized Clinical Trial
Nallamothu, B. K., Hayward, R. A., & Bates, E. (2008) · Circulation · doi:10.1161/circulationaha.107.703579 · Cited by 253
Mohr, B. A., Guay, A. T., O’Donnell, A. B., & McKinlay, J. B. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02174.x · Cited by 248
Novel Mechanisms Responsible for Postmenopausal Hypertension
Reckelhoff, J. F., & Fortepiani, L. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000124670.03674.15 · Cited by 244
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.012 · Cited by 242
VanderWeele, T. J. (2017) · Epidemiology · doi:10.1097/ede.0000000000000641 · Cited by 236
Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After Menopause
Prentice, R. L., Manson, J. E., Langer, R. D., Anderson, G. L., Pettinger, M. B., Jackson, R. D., Johnson, K., Kuller, L. H., Lane, D. S., Wactawski‐Wende, J., et al. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp115 · Cited by 234
Self-citationEvans, M. L., Pritts, E. A., Vittinghoff, E., McClish, K., Morgan, K. S., & Jaffe, R. B. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000147840.06947.46 · Cited by 231
Genetic Risk Factors for Portopulmonary Hypertension in Patients with Advanced Liver Disease
Roberts, K. E., Fallon, M. B., Krowka, M. J., Brown, R. S., Trotter, J. F., Peter, I., Tighiouart, H., Knowles, J. A., Rabinowitz, D., Benza, R. L., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1472oc · Cited by 230
Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?
Cho, L., Kaunitz, A. M., Faubion, S. S., Hayes, S. N., Lau, E. S., Pristera, N., Scott, N. S., Shifren, J. L., SHUFELT, C. L., Stuenkel, C. A., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061559 · Cited by 242
The Target Trial Framework for Causal Inference From Observational Data: Why and When Is It Helpful?
Hernán, M. Á., Dahabreh, I. J., Dickerman, B. A., & Swanson, S. A. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-01871 · Cited by 228
Barton, M., & Meyer, M. R. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.120022 · Cited by 231
Sleep Complaints in Community‐Living Older Persons: A Multifactorial Geriatric Syndrome
Fragoso, C. A. V., & Gill, T. M. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01399.x · Cited by 226
The Women's Health Initiative Steering Committee (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.06.061 · Cited by 220
Estrogen Receptor Signaling in Breast Cancer
Miziak, P. A., Baran, M. T., Błaszczak, E., Przybyszewska-Podstawka, A., Kałafut, J., Smok-Kalwat, J., Dmoszyńska‐Graniczka, M., Kiełbus, M., & Stepulak, A. (2023) · Cancers · doi:10.3390/cancers15194689 · Cited by 228
Madalinska, J. B., van Beurden, M., Bleiker, E. M. A., Valdimarsdottir, H. B., Hollenstein, J., Massuger, L. F. A. G., Gaarenstroom, K. N., Mourits, M. J. E., Verheijen, R. H. M., van Dorst, E. B. L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1896 · Cited by 218
Maric, C., Sandberg, K. L., & Hinojosa‐Laborde, C. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000128219.65330.ea · Cited by 214
Oestrogen and anti-androgen therapy for transgender women
Tangpricha, V., & den Heijer, M. (2016) · The Lancet Diabetes and Endocrinology · doi:10.1016/s2213-8587(16)30319-9 · Cited by 170
Piarroux, R., Grenouillet, F., Balvay, P., Tran, V., Blasco, G., Millon, L., & Boillot, A. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000147726.62304.7f · Cited by 215
Moreau, K. L., Stauffer, B. L., Kohrt, W. M., & Seals, D. R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2183 · Cited by 222
Screening for Osteoporosis: An Update for the U.S. Preventive Services Task Force
Nelson, H. D., Haney, E. M., Dana, T., Bougatsos, C., & Chou, R. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-2-201007200-00262 · Cited by 214
Stefanick, M. L. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.059 · Cited by 212
Norman, P. E., & Powell, J. T. (2007) · Circulation · doi:10.1161/circulationaha.106.671859 · Cited by 209
Efficacy and Safety of Isopropanolic Black Cohosh Extract for Climacteric Symptoms
Osmers, R. G. W., Friede, M., Liske, E., Schnitker, J., Freudenstein, J., & Zepelin, H. H. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000158865.98070.89 · Cited by 209
Ayers, B., Smith, M., Hellier, J., Mann, E., & Hunter, M. S. (2012) · Menopause · doi:10.1097/gme.0b013e31823fe835 · Cited by 207
Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy
Streed, C. G., Harfouch, O., Marvel, F. A., Blumenthal, R. S., Martin, S. S., & Mukherjee, M. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0577 · Cited by 207
Risks, Benefits, and Treatment Modalities of Menopausal Hormone Therapy: Current Concepts
Mehta, J. M., Kling, J. M., & Manson, J. E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.564781 · Cited by 206
Self-citationExogenous Progesterone Attenuates the Subjective Effects of Smoked Cocaine in Women, but not in Men
Evans, S. M., & Foltin, R. W. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300887 · Cited by 204
Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist
Mersereau, J. E., Levy, N., Staub, R. E., Baggett, S., Zogric, T., Chow, S., Ricke, W. A., Tagliaferri, M. A., Cohen, I. V., Bjeldanes, L. F., et al. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.11.020 · Cited by 199
Propensity Score: an Alternative Method of Analyzing Treatment Effects
Kuß, O., Blettner, M., & Börgermann, J. (2016) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2016.0597 · Cited by 212
Sex Differences in Perceived Risks, Distrust, and Willingness to Participate in Clinical Trials
Ding, E. L. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.905 · Cited by 204
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.012 · Cited by 192
Postmenopausal Hormone Therapy and Stroke
Grodstein, F., Manson, J. E., Stampfer, M. J., & Rexrode, K. M. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.861 · Cited by 191
Self-citationEquipoise and the Dilemma of Randomized Clinical Trials
Miller, F. G., & Joffe, S. (2011) · New England Journal of Medicine · doi:10.1056/nejmsb1011301 · Cited by 189
Clarkson, T. B. (2007) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31803c764d · Cited by 187
Cobin, R. H., Futterweit, W., Ginzburg, S. B., Goodman, N. F., Kleerekoper, M., Licata, A. A., Meikle, A. W., Petak, S. M., Porte, K. L., Sellin, R. V., et al. (2006) · Endocrine Practice · doi:10.4158/ep.12.3.315 · Cited by 184
Management of osteoporosis in postmenopausal women
(2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000222475.93345.b3 · Cited by 185
Hormone Replacement Therapy and Lung Cancer Risk
Schabath, M. B., Wu, X., Vassilopoulou‐Sellin, R., Vaporciyan, A. A., & Spitz, M. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0911-3 · Cited by 183
Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms
GELLER, S. E., SHULMAN, L. P., van Breemen, R. B., Banuvar, S., Zhou, Y., Epstein, G., Hedayat, S., Nikolic, D. S., Krause, E. C., Piersen, C. E., et al. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181ace49b · Cited by 181
Newman, C. B., Blaha, M. J., Boord, J. B., Cariou, B., Chait, A., Fein, H. G., Ginsberg, H. N., Goldberg, I. J., Murad, M. H., Subramanian, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa674 · Cited by 182
Atteritano, M., Marini, H. R., Minutoli, L., Polito, F., Bitto, A., Altavilla, D., Mazzaferro, S., D’Anna, R., Cannata, M. L., Gaudio, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2295 · Cited by 176
Collins, P. D., Rosano, G. M. C., Casey, C., Daly, C., Gambacciani, M., Hadji, P., Kaaja, R., Mikkola, T. S., Palacios, S., Preston, R. A., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm296 · Cited by 178
Kim, J., Kim, J. Y., Song, K. S., Lee, Y. H., Seo, J. S., Jelı́nek, J., Goldschmidt‐Clermont, P. J., & Issa, J. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.004 · Cited by 174
Huxley, V. H. (2007) · AJP Advances in Physiology Education · doi:10.1152/advan.00099.2006 · Cited by 173
Sex Steroids, Cardiovascular Disease, and Hypertension
Reckelhoff, J. F. (2004) · Hypertension · doi:10.1161/01.hyp.0000151825.36598.36 · Cited by 165
Increased Carotid Atherosclerosis in Andropausal Middle-Aged Men
Mäkinen, J. I., Järvisalo, M. J., Pöllänen, P., Perheentupa, A. H., Irjala, K. M. A., Koskenvuo, M. J., Mäkinen, J., Huhtaniemi, I. T., & Raitakari, O. T. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.052 · Cited by 164
Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women
Gartlehner, G., Patel, S. V., Feltner, C., Weber, R. P., de Long, R., Mullican, K., Boland, E., Lux, L. J., & Viswanathan, M. (2017) · JAMA · doi:10.1001/jama.2017.16952 · Cited by 166
Simoncini, T., Mannella, P., Fornari, L., Caruso, A., Willis, M. Y., Garibaldi, S., Baldacci, C., & Genazzani, A. R. (2004) · Endocrinology · doi:10.1210/en.2004-0510 · Cited by 163
Examining the Use of Real‐World Evidence in the Regulatory Process
Beaulieu‐Jones, B. K., Finlayson, S. G., Yuan, W., Altman, R. B., Kohane, I. S., Prasad, V. K., & Yu, K. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1658 · Cited by 169
Ransohoff, D. F. (2007) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.04.020 · Cited by 161
Denes, P. (2007) · JAMA · doi:10.1001/jama.297.9.978 · Cited by 160
Alekel, D. L., Loan, M. D. V., Koehler, K. J., Hanson, L. N., Stewart, J. W., Hanson, K. B., Kurzer, M. S., & Peterson, C. T. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28306 · Cited by 160
Sex Differences in Carotid Plaque and Stenosis
Iemolo, F., Martiniuk, A. L. C., Steinman, D. A., & Spence, J. D. (2004) · Stroke · doi:10.1161/01.str.0000110981.96204.64 · Cited by 160
Prentice, R. L., Langer, R. D., Stefanick, M. L., Howard, B. V., Pettinger, M. B., Anderson, G. L., Barad, D. H., Curb, J. D., Kotchen, J. M., Kuller, L. H., et al. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj079 · Cited by 162
Sex Differences in Circulating Biomarkers of Cardiovascular Disease
Lau, E. S., Paniagua, S. M., Guseh, J. S., Bhambhani, V., Zanni, M. V., Courchesne, P. L., Lyass, A., Larson, M. G., Levy, D. A., & Ho, J. E. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.06.077 · Cited by 159
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE)
Chertow, G. M., Pupim, L. B., Block, G. A., Correa‐Rotter, R., Drüeke, T. B., Floege, J., Goodman, W. G., London, G. M., Mahaffey, K. W., Moe, S. M., et al. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04381206 · Cited by 158
Changing Concepts: Menopausal Hormone Therapy and Breast Cancer
Chlebowski, R. T., & Anderson, G. L. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs014 · Cited by 161
Uddin, M. S., Rahman, M. M., Jakaria, M., Rahman, M. S., Hossain, M. S., Islam, A., Ahmed, M., Mathew, B., Omar, U. M., Barreto, G. E., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01911-8 · Cited by 156
The metabolic syndrome in women
Bentley–Lewis, R., Koruda, K., & Seely, E. W. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0616 · Cited by 159
Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study
Hsia, J. A., Larson, J. C., Ockene, J. K., Sarto, G. E., Allison, M., Hendrix, S. L., Robinson, J. G., LaCroix, A. Z., & Manson, J. E. (2009) · BMJ · doi:10.1136/bmj.b219 · Cited by 152
Self-citationInstitute of Medicine (2013) · National Academies Press eBooks · doi:10.17226/13444 · Cited by 170
Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
Rozenberg, S., Al-Daghri, N., Aubertin-Leheudre, M., Brandi, M.-L., Cano, A., Collins, P., Cooper, C., Genazzani, A. R., Hillard, T., Kanis, J. A., et al. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05497-8 · Cited by 149
Naftolin, F. N., Taylor, H. S., Karas, R. H., Brinton, E. A., Newman, I., Clarkson, T. B., Mendelsohn, M. E., Løbo, R. A., Judelson, D. R., Nachtigall, L. E., et al. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.02.095 · Cited by 149
Cancer Prevention: From 1727 to Milestones of the Past 100 Years
Lippman, S. M., & Hawk, E. T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1750 · Cited by 151
Age- and Gender-Specific Changes in the Left Ventricular Relaxation
Okura, H., Takada, Y., Yamabe, A., Kubo, T., Asawa, K., Ozaki, T., Yamagishi, H., Toda, I., Yoshiyama, M., Yoshikawa, J., et al. (2009) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.809087 · Cited by 147
Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women
Honigberg, M. C., Zekavat, S. M., Niroula, A., Griffin, G. K., Bick, A. G., Pirruccello, J. P., Nakao, T., Whitsel, E. A., Farland, L. V., Laurie, C. A., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.051775 · Cited by 150
Self-citationAre All Estrogens Created Equal? A Review of Oral vs. Transdermal Therapy
Goodman, M. P. (2011) · Journal of Women s Health · doi:10.1089/jwh.2011.2839 · Cited by 146
Menopausal hormone therapy and menopausal symptoms
Al-Safi, Z. A., & Santoro, N. F. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.032 · Cited by 145
Hunter, M. S., Gentry‐Maharaj, A., Ryan, A., Burnell, M., Lanceley, A., Fraser, L. S. M., Jacobs, I. J., & Menon, U. (2011) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03166.x · Cited by 147
Hormone Therapy Increases Risk of Ulcerative Colitis but not Crohn's Disease
Khalili, H., Higuchi, L. M., Ananthakrishnan, A. N., Manson, J. E., Feskanich, D., Richter, J. M., Fuchs, C. S., & Chan, A. T. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.096 · Cited by 142
Self-citationTreatment of menopausal symptoms: what shall we do now?
Hickey, M., Davis, S. R., & Sturdee, D. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66519-1 · Cited by 145
South African hypertension guideline 2006.
Seedat, Y. K., Ma, C., Milne, F. J., Opie, L. H., Vj, P.-A., Rayner, B. L., & Veriava, Y. (2006) · PubMed · Cited by 141
Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women
Prentice, R. L., Chlebowski, R. T., Stefanick, M. L., Manson, J. E., Pettinger, M. B., Hendrix, S. L., Hubbell, F. A., Kooperberg, C. L., Kuller, L. H., Lane, D. S., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn044 · Cited by 140
Self-citationLipids, Lipoproteins, Apolipoproteins, and Other Cardiovascular Risk Factors
Remaley, A. T., Rifai, N., & Warnick, G. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6164-9.00027-5 · Cited by 139
Testosterone treatment comes of age: new options for hypogonadal men
Nieschlag, E. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02618.x · Cited by 137
Miller, V. M., Black, D. M., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hodis, H. N., Løbo, R. A., Manson, J. E., Merriam, G. R., Naftolin, F. N., et al. (2009) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-009-9104-y · Cited by 139
Self-citationThe 2020 Menopausal Hormone Therapy Guidelines
Lee, S. R., Cho, M. K., Cho, Y. J., Chun, S., Hong, S.-H., Hwang, K. R., Jeon, G., Joo, J. K., Kim, S. K., Lee, D. O., et al. (2020) · Journal of Menopausal Medicine · doi:10.6118/jmm.20000 · Cited by 136
Coronary heart disease: the female heart is vulnerable
WENGER, N. K. (2003) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2003.08.003 · Cited by 139
A cognitive model of menopausal hot flushes and night sweats
Hunter, M. S., & Mann, E. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2010.04.005 · Cited by 139
Si, H., & Liu, D. (2008) · Journal of Nutrition · doi:10.1093/jn/138.2.297 · Cited by 135
Postmenopausal hormone therapy: new questions and the case for new clinical trials
Manson, J. E., Bassuk, S. S., Harman, S. M., Brinton, E. A., Cedars, M. I., Løbo, R. A., Merriam, G. R., Miller, V. M., Naftolin, F. N., & Santoro, N. F. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000177906.94515.ff · Cited by 135
Self-citationKris‐Etherton, P. M., & Krauss, R. M. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa110 · Cited by 145
Inclusion of Stroke in Cardiovascular Risk Prediction Instruments
Lackland, D. T., Elkind, M. S. V., D’Agostino, R. B., Dhamoon, M. S., Goff, D. C., Higashida, R. T., McClure, L. A., Mitchell, P. H., Sacco, R. L., Sila, C. A., et al. (2012) · Stroke · doi:10.1161/str.0b013e31825bcdac · Cited by 136
Postmenopausal hormone therapy: risks and benefits
Rozenberg, S., Vandromme, J., & Antoine, C. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.17 · Cited by 132
Metadata
- Authors
- Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., Strickland, O. L., Wong, N. D., Crouse, J. R., Stein, E., & Cushman, M.
- Affiliations
- Brigham and Women's Hospital (US)
- George Washington University (US)
- University of Tennessee Health Science Center (US)
- National Heart, Lung, and Blood Institute (US)
- Memorial Hospital of Rhode Island (US)
- Rutgers New Jersey Medical School (US)
- University at Buffalo, State University of New York (US)
- Rush University Medical Center (US)
- University of Washington (US)
- University of California, Los Angeles (US)
- Emory University (US)
- University of California, Irvine (US)
- Wake Forest University (US)
- University of Vermont (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-08-07
- Volume
- 349
- Issue
- 6
- Pages
- 523-534
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1981922048
- Cited by
- 2,065
- References
- 35
- Citations by year
- 2026: 32 · 2025: 43 · 2024: 34 · 2023: 32 · 2022: 33 · 2021: 43 · 2020: 51 · 2019: 48 · 2018: 51 · 2017: 59 · 2016: 42 · 2015: 67 · 2014: 73 · 2013: 109 · 2012: 99
- FWCI
- 123.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- estrogen plus progestin, coronary artery disease, hormone replacement therapy, Women's Health Initiative, postmenopausal women, conjugated equine estrogens, medroxyprogesterone acetate, myocardial infarction, cardiovascular risk, LDL cholesterol, C-reactive protein, trial termination
- MeSH terms
- Aged, Coronary Disease, Double-Blind Method, Drug Combinations, Estrogens, Conjugated (USP), Female, Follow-Up Studies, Heart Diseases, Humans, Middle Aged, Myocardial Infarction, Risk Factors, Proportional Hazards Models, Case-Control Studies, Treatment Outcome, Medroxyprogesterone Acetate, Postmenopause, Hormone Replacement Therapy, Progesterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
